Search

everythinglearnresearchcommunity

for

Search:↓

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Finasteride cream helps hair growth with less side effects.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

A gene mutation in mice causes permanent hair loss and skin issues.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.